Evaluation of Radiolabeled Girentuximab In Vitro and In Vivo
Girentuximab (cG250) targets carbonic anhydrase IX (CAIX), a protein which is expressed on the surface of most renal cancer cells (RCCs). cG250 labeled with <sup>177</sup>Lu has been used in clinical trials for radioimmunotherapy (RIT) of RCCs. In this work, an extensive characterization...
Spremljeno u:
Glavni autori: | , , , , , , , , , , |
---|---|
Format: | Knjiga |
Izdano: |
MDPI AG,
2018-11-01T00:00:00Z.
|
Teme: | |
Online pristup: | Connect to this object online. |
Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|
Internet
Connect to this object online.3rd Floor Main Library
Signatura: |
A1234.567 |
---|---|
Primjerak 1 | Dostupno |